https://www.msn.com/en-au/news..../australia/scott-mor

Clot shot “vaccines” create BOOM in blood clot removal industry

An arterial embolism is a deep blood clot that requires hospitalization and costs about $100,000 or more because it requires bypass surgery. There is an entirely NEW revenue model from blood clots caused by the COVID “vaccines,” and Big Pharma companies are not only taking advantage of the profit scheme, but may have known it was coming before the “clot shots” were even rushed out “emergency” style.

One company, for example, Royal Philips, has expanded significantly into the market of PMT devices (percutaneous mechanical thrombectomy) for removing clots from peripheral and coronary vessels, and their massive “investments” began in August of 2020, right before the “pandemic” hit, including the mad, mad rush to get “vaccinated” for Wuhan Flu. Coincidence?

Did Royal Philips, a global health tech company, know in advance that COVID “vaccines” cause blood clots when they invested heavily in PMT in 2020?

Percutaneous mechanical thrombectomy (PMT) devices are increasingly being used to treat blood clots caused by Pfizer, Moderna and J&J coronavirus “vaccines.” This type of blood clot removal is a faster treatment option than the traditional CDT (catheter-directed thrombolysis) or lytic (thrombolytic) procedures. Yes, the “image-guided” blood clot therapy business is skyrocketing, and certain companies are all over it, making a fortune, while buying out other companies and investing heavily in specific equipment and implantable devices, and thus expanding their “portfolio.”

Philips acquired Intact Vascular in the third quarter of 2020 with $275 million in cash and another $85 million after completion, expanding the company’s blood clot tech business just in time for the apocalyptic rush of mysterious blood clot incidents following the mass (forced) vaccination program across the nation. Now, just like the pacemaker market, the blood clot tech market is taking off. Who knew about all the myocarditis and blood clot side effects of the vaccines before they even came out?

Blood clot implant devices leave “less metal” behind compared to stents when it comes to treating vaccine-induced blood clots

There’s big money in treating blood clots, so why not capitalize early on a wave of blood clots that come from getting gene therapy injections for Wuhan Virus? After all, America is built on capitalism. The patient population that needs blood clot therapy has exponentially expanded, including young healthy people, athletes, military members and even children, thanks to the Fauci Flu clot shots. There are aspiration pumps and catheters for those hard to reach clots in peripheral veins and arteries. Big Pharma’s got you covered. They planned well for it. The FDA cleared the whole industry for pre-pandemic “take off.”
@NaturalNewsMedia

?????? Read more ??????

Clot shot “vaccines” create BOOM in blood clot removal industry

An arterial embolism is a deep blood clot that requires hospitalization and costs about $100,000 or more because it requires bypass surgery. There is an entirely NEW revenue model from blood clots caused by the COVID “vaccines,” and Big Pharma companies are not only taking advantage of the profit scheme, but may have known it was coming before the “clot shots” were even rushed out “emergency” style.

One company, for example, Royal Philips, has expanded significantly into the market of PMT devices (percutaneous mechanical thrombectomy) for removing clots from peripheral and coronary vessels, and their massive “investments” began in August of 2020, right before the “pandemic” hit, including the mad, mad rush to get “vaccinated” for Wuhan Flu. Coincidence?

Did Royal Philips, a global health tech company, know in advance that COVID “vaccines” cause blood clots when they invested heavily in PMT in 2020?

Percutaneous mechanical thrombectomy (PMT) devices are increasingly being used to treat blood clots caused by Pfizer, Moderna and J&J coronavirus “vaccines.” This type of blood clot removal is a faster treatment option than the traditional CDT (catheter-directed thrombolysis) or lytic (thrombolytic) procedures. Yes, the “image-guided” blood clot therapy business is skyrocketing, and certain companies are all over it, making a fortune, while buying out other companies and investing heavily in specific equipment and implantable devices, and thus expanding their “portfolio.”

Philips acquired Intact Vascular in the third quarter of 2020 with $275 million in cash and another $85 million after completion, expanding the company’s blood clot tech business just in time for the apocalyptic rush of mysterious blood clot incidents following the mass (forced) vaccination program across the nation. Now, just like the pacemaker market, the blood clot tech market is taking off. Who knew about all the myocarditis and blood clot side effects of the vaccines before they even came out?

Blood clot implant devices leave “less metal” behind compared to stents when it comes to treating vaccine-induced blood clots

There’s big money in treating blood clots, so why not capitalize early on a wave of blood clots that come from getting gene therapy injections for Wuhan Virus? After all, America is built on capitalism. The patient population that needs blood clot therapy has exponentially expanded, including young healthy people, athletes, military members and even children, thanks to the Fauci Flu clot shots. There are aspiration pumps and catheters for those hard to reach clots in peripheral veins and arteries. Big Pharma’s got you covered. They planned well for it. The FDA cleared the whole industry for pre-pandemic “take off.”
@NaturalNewsMedia

?????? Read more ??????

https://cairnsnews.org/2022/05..../04/put-majors-last-